GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Apontis Pharma AG (XTER:APPH) » Definitions » Price-to-Operating-Cash-Flow

Apontis Pharma AG (XTER:APPH) Price-to-Operating-Cash-Flow : (As of Jul. 20, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Apontis Pharma AG Price-to-Operating-Cash-Flow?

As of today (2025-07-20), Apontis Pharma AG's share price is €10.80. Apontis Pharma AG's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2024 was €-0.34. Hence, Apontis Pharma AG's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Apontis Pharma AG's Price-to-Operating-Cash-Flow or its related term are showing as below:

During the past 7 years, Apontis Pharma AG's highest Price-to-Operating-Cash-Flow Ratio was 150.29. The lowest was 2.41. And the median was 23.54.

XTER:APPH's Price-to-Operating-Cash-Flow is not ranked *
in the Drug Manufacturers industry.
Industry Median: 18.905
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Apontis Pharma AG's Cash Flow from Operations per share for the six months ended in Dec. 2024 was €0.12. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2024 was €-0.34.


Apontis Pharma AG Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Apontis Pharma AG's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Apontis Pharma AG Price-to-Operating-Cash-Flow Chart

Apontis Pharma AG Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Price-to-Operating-Cash-Flow
Get a 7-Day Free Trial - 46.53 6.20 - -

Apontis Pharma AG Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.20 - - - -

Competitive Comparison of Apontis Pharma AG's Price-to-Operating-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, Apontis Pharma AG's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Apontis Pharma AG's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Apontis Pharma AG's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Apontis Pharma AG's Price-to-Operating-Cash-Flow falls into.


;
;

Apontis Pharma AG Price-to-Operating-Cash-Flow Calculation

Apontis Pharma AG's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=10.80/-0.339
=

Apontis Pharma AG's Share Price of today is €10.80.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Apontis Pharma AG's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2024 was €-0.34.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

Apontis Pharma AG Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Apontis Pharma AG's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Apontis Pharma AG Business Description

Traded in Other Exchanges
Address
Rolf-Schwarz-Schutte-Platz 1, Monheim, BY, DEU, 40789
Apontis Pharma AG is a pharmaceutical company specializing in single pills in Germany. single pills combine two to three generic active ingredients in a single dosage form. The company develops, promotes, and sells a broad portfolio of single pills and other pharmaceutical products, with a special focus on cardiovascular diseases. The company markets drugs in the disease areas of respiratory diseases and diabetes as part of co-marketing/co-promotion.
Executives
Bruno Wohlschlegel Board of Directors
Thomas Milz Board of Directors
Thomas Zimmermann Chief Financial Officer
Karlheinz Gast Board of Directors

Apontis Pharma AG Headlines

No Headlines